Oligometastatic prostate cancer, where the cancer has spread to a few sites, can be effectively managed with stereotactic radiotherapy. This precise treatment targets metastatic lesions with minimal side effects, helping to delay the need for more aggressive therapies. Pinpoint Radiotherapy is dedicated to providing compassionate and advanced care, supported by evidence from the TRANSFORM trial we conducted, and other research.
Understanding Oligometastatic Prostate Cancer
When prostate cancer spreads beyond the prostate to a few specific sites, it’s known as oligometastatic disease. This condition can be challenging, but it also provides an opportunity to manage the cancer effectively and maintain quality of life for longer. Typically, treatment for metastatic prostate cancer involves systemic therapies like hormone therapy or chemotherapy, which can come with significant side effects and impact your everyday life.
For those with oligometastatic prostate cancer, a more targeted approach can make a big difference. Instead of treating the whole body, stereotactic radiotherapy (SABR) focuses precisely on the metastatic sites, aiming to control the disease locally and delay the need for more extensive treatments. This can mean a longer period of stability and fewer interruptions to your daily life.
What is Stereotactic Radiotherapy (SABR)?
SBRT is a type of radiation therapy that delivers high doses of radiation to very specific areas in just a few sessions. It’s like using a laser beam to carefully target only the cancer cells, sparing the surrounding healthy tissue as much as possible. This is particularly useful for treating oligometastatic prostate cancer, where the goal is to control small, defined areas of spread.
The TRANSFORM trial, a major study in this area, showed that using SBRT to treat all visible metastatic sites can delay the need for further systemic therapy, allowing patients to maintain a better quality of life for longer. Other studies have reported similar findings, with local control rates over 90% and extended periods before the cancer progresses. This approach helps to manage the cancer more effectively while reducing the burden of treatment.
How Pinpoint Radiotherapy Can Help
At Pinpoint Radiotherapy, we’re passionate about providing advanced, patient-centred care. We know that every cancer journey is different, and we’re here to offer treatments that are tailored to your specific needs and circumstances. Our focus on stereotactic radiotherapy means we’re equipped to deliver this precise treatment, with the goal of controlling your cancer while maintaining your quality of life.
We have:
- Expertise in SABR: We have extensive experience in using stereotactic radiotherapy for prostate cancer, particularly for treating metastatic disease. Our team is skilled in planning and delivering this therapy with the utmost precision. Our team have provided thousands of courses of SABR treatment in the past decade.
- A Personalised Approach: We take the time to understand your situation and discuss all available options with you. You’ll have the opportunity to ask questions and make informed choices about your care.
- Advanced Technology: We use cutting-edge imaging and radiation equipment to ensure the most accurate treatment possible. This means we can target the cancer effectively while minimising side effects.
- Support Throughout Your Journey: We work closely with your broader healthcare team, including your urologist and medical oncologist, to ensure that your treatment is well-coordinated and aligned with your overall care plan.
The Future of Oligometastatic Prostate Cancer Treatment
SABR is becoming an increasingly important part of managing oligometastatic prostate cancer. It offers a way to control the disease locally and delay the need for further therapies, helping you to continue living your life as fully as possible. The evidence, including results from the TRANSFORM trial, shows that this approach can make a real difference for many patients.
At Pinpoint Radiotherapy, we’re committed to staying at the forefront of these advancements, providing compassionate care that’s backed by the latest research and technology.
Conclusion
For men with oligometastatic prostate cancer, stereotactic radiotherapy offers a way to manage the disease more effectively, with fewer side effects and a greater focus on preserving your quality of life. If you’re interested in learning more about how this treatment could fit into your overall care plan, we’re here to help. At Pinpoint Radiotherapy, we’re committed to providing the highest level of care and support for you and your family.